Janney Starts Marinus Pharmaceuticals (MRNS) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
JMP Securities Starts Marinus Pharmaceuticals (MRNS) at Market Outperform
August 26, 2014 8:23 AM EDTJMP Securities initiated coverage on Marinus Pharmaceuticals (NASDAQ: MRNS) with a Market Outperform rating and a price target of $14.00.
For an analyst ratings summary and ratings history on Marinus Pharmaceuticals click here. For more ratings news on Marinus Pharmaceuticals click here.
Shares of Marinus Pharmaceuticals closed at $8.04 yesterday.
... MoreStifel Nicolaus Starts Marinus Pharmaceuticals (MRNS) at Buy
August 25, 2014 7:15 AM EDTStifel Nicolaus initiated coverage on Marinus Pharmaceuticals (NASDAQ: MRNS) with a Buy rating and a price target of $11.00.
For an analyst ratings summary and ratings history on Marinus Pharmaceuticals click here. For more ratings news on Marinus Pharmaceuticals click here.
Shares of Marinus Pharmaceuticals closed at $8.04 yesterday.
... More